R-5-Methoxyindolyl Propanamine Fumarate Polymorphs for Stability
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The development of (R)-1-(5-methoxy-1H-indol-1-yl)-N,N-dimethylpropan-2-amine is limited by difficulties in formulating salt and solid forms, including (R)-1-(5-methoxy-1H-indol-1-yl)-N,N-dimethylpropan-2-amine fumarate.
Innovation Solution
The development of novel crystalline polymorphic forms of (R)-1-(5-methoxy-1H-indol-1-yl)-N,N-dimethylpropan-2-amine fumarate with improved properties such as melting point, glass transition temperature, flowability, thermal stability, and solubility, among others, compared to amorphous forms.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Stability of the object's composition
If amorphous forms of (R)-1-(5-methoxy-1H-indol-1-yl)-N,N-dimethylpropan-2-amine fumarate are used, then formulation is simpler, but physical and chemical stability is poor
Solution Approach 1:
The patent applies parameter changes by transitioning from amorphous to crystalline forms, fundamentally altering the physical state parameters of the compound. This phase transition from amorphous to crystalline structure resolves the stability issue while maintaining formulation feasibility through systematic exploration of different crystalline polymorphs
Solution Approach 2:
The patent directly applies phase transitions by developing crystalline polymorphic forms from amorphous precursors. The process involves controlled phase transitions during crystallization, where the compound transforms from an unstable amorphous state to stable crystalline states with defined melting points and structural characteristics
2Reliability
If novel crystalline polymorphic forms are developed, then stability and bioavailability are improved, but development time and complexity increase
Solution Approach 1:
The patent applies preliminary action by systematically characterizing and documenting multiple crystalline polymorphic forms upfront, including their stability profiles, solubility characteristics, and bioavailability parameters. This preliminary characterization of different polymorphs establishes a foundation for future formulation work, reducing development time for subsequent stages
Solution Approach 2:
The patent systematically varies crystallization parameters such as solvent type, temperature, and concentration to generate and characterize different polymorphic forms. By exploring parameter space methodically, the patent identifies optimal crystalline forms with improved stability and bioavailability while documenting the development process to reduce future development time
3Ease of manufacture
If crystalline polymorphic forms are used, then thermal stability and flowability are improved, but manufacturing process complexity increases
Solution Approach 1:
The patent optimizes manufacturing parameters by establishing specific crystallization conditions, drying temperatures, and storage parameters for each polymorphic form. These parameter optimizations improve flowability and thermal stability while standardizing the manufacturing process to reduce complexity through defined operating ranges and protocols
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The crystalline polymorphic forms exhibit enhanced physical, chemical, and pharmacokinetic properties, improving stability, bioavailability, and compatibility with excipients, suitable for pharmaceutical compositions targeting neurological and psychiatric disorders.
Implementation Method 1
The development of novel crystalline polymorphic forms of (R)-1-(5-methoxy-1H-indol-1-yl)-N,N-dimethylpropan-2-amine fumarate with improved properties such as melting point, glass transition temperature, flowability, thermal stability
Data Source
AI summary
The present disclosure is directed to salt and solid forms of (R)-1-(5-METHOXY-1H-INDOL-1-YL)-N,N-DIMETHYLPROPAN-2-AMINE and methods of treating neurological disorder and/or a psychiatric disorder in a subject in need thereof.